- Report
- October 2024
- 100 Pages
Global
From €3500EUR$4,191USD£3,185GBP
- Report
- December 2023
- 231 Pages
Global
€4469EUR$4,995USD£3,929GBP
- Report
- February 2024
- 234 Pages
Global
€4469EUR$4,995USD£3,929GBP
- Report
- April 2023
- 150 Pages
Global
From €3444EUR$3,850USD£3,028GBP
€4339EUR$4,850USD£3,815GBP
- Report
- August 2023
- 300 Pages
Latin America
From €4384EUR$4,900USD£3,854GBP
- Report
- August 2023
- 300 Pages
Asia Pacific
From €4384EUR$4,900USD£3,854GBP
- Report
- August 2023
- 300 Pages
Europe
From €4384EUR$4,900USD£3,854GBP
- Report
- August 2023
- 300 Pages
Middle East, Africa
From €4384EUR$4,900USD£3,854GBP
- Report
- August 2023
- 1350 Pages
Global
From €7962EUR$8,900USD£7,000GBP
- Report
- August 2023
- 51 Pages
India
From €537EUR$600USD£472GBP
- Report
- August 2023
- 51 Pages
Argentina
From €537EUR$600USD£472GBP
- Report
- August 2023
- 51 Pages
South Korea
From €537EUR$600USD£472GBP
From €537EUR$600USD£472GBP
- Report
- August 2023
- 51 Pages
South Africa
From €537EUR$600USD£472GBP
- Report
- August 2023
- 51 Pages
Australia
From €537EUR$600USD£472GBP
- Report
- August 2023
- 51 Pages
Japan
From €537EUR$600USD£472GBP
- Report
- August 2023
- 51 Pages
Saudi Arabia
From €537EUR$600USD£472GBP
- Report
- August 2023
- 51 Pages
Israel
From €537EUR$600USD£472GBP
- Report
- August 2023
- 51 Pages
Colombia
From €537EUR$600USD£472GBP
- Report
- August 2023
- 51 Pages
Mexico
From €537EUR$600USD£472GBP

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more